Federal Practitioner articles are now available in PubMed Central, which provides full text access to any reader and is included in all PubMed online searches.
Federal Practitioner is inviting VA, DoD, and PHS health care providers and researchers to contribute to the May 2018 and August 2018 Advances in Hematology and Oncology special issues. The special issues are produced in cooperation with the Association of VA Hematology/Oncology (AVAHO). The journal is especially interested in articles on lung, prostate, and head and neck cancers; melanoma and skin cancers; survivorship; patient navigation; lymphomas; leukemias; multiple myeloma; neuroendocrine tumors; and immunotherapies.
Interested authors can send a brief 2 to 3 sentence abstract to email@example.com by March 15, 2018, or submit a completed article directly into Editorial Manager, a web-based manuscript submission and review system. Federal Practitioner welcomes case studies, literature reviews, original research, program profiles, guest editorials, and other evidence-based articles. The updated and complete submission guidelines, including details about the style and format, can be found here:
All manuscripts submitted to Federal Practitioner for both special and regular issues will be subject to peer review. Peer reviews are conducted in a double-blind fashion, and the reviewers are asked to comment on the manuscript’s importance, accuracy, relevance, clarity, timeliness, balance, and reference citation. Final decisions on all submitted manuscripts are made by the Editorial Advisory Association Hematology/Oncology special issue advisory board.